Treatment as Prevention: HAART expansion – a powerful strategy to reduce AIDS morbidity and mortality and HIV

Widespread availability of HAART has dramatically decreased AIDS-related diseases and death since 1996. Furthermore, HAART rapidly and effectively renders HIV undetectable in blood and genital secretions and this is associated with decreased risk of transmission. HAART is therefore the best and most cost-effective means to stop disease progression and death, as well as HIV transmission: the strategy has now been named “Treatment as Prevention” (TasP).

For more information, please download the event flyer.


Event Details

Days
Hours
Minutes
Seconds
Start Date
  • September 6, 2012 15:00
End Date
  • September 6, 2012 16:00
Email
education@bccfe.ca
Event Category
  • Lecture
Calendar of Events
Click here for the Calendar of Events
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below

Laboratory Order Forms

Start typing and press enter to search